Severe phenotypes in a Charcot-Marie-Tooth 1A patient with PMP22 triplication

J Hum Genet. 2015 Feb;60(2):103-6. doi: 10.1038/jhg.2014.102. Epub 2014 Dec 11.

Abstract

Charcot-Marie-Tooth disease (CMT) is a genetically and clinically heterogeneous hereditary motor and sensory neuropathy signified by a distal symmetric polyneuropathy. The most frequent subtype is type 1A (CMT1A) caused by duplication in chromosome 17p12 that includes PMP22. This study reports a woman with a family history of CMT1A due to PMP22 duplication. However, she presented with a more severe phenotype than her sibling or ancestors and was found to have a PMP22 triplication instead of the duplication. This was caused by de novo mutation on her affected mother's duplication chromosome. Her lower limb magnetic resonance imaging revealed severe diffused atrophy and fatty replacement. However, her affected sister with typical PMP22 duplication showed almost intact lower limb. Triplication patient's median motor nerve conduction velocity was far lower compared with her sister. Her onset age was faster (8 years) than her sister (42 years). CMT1A triplication might be generated by a female-specific chromosomal rearrangement mechanism that is different from the frequent paternal-originated CMT1A duplication. It also suggests that the wide phenotypic variation of CMT1A might be partly caused by unstable genomic rearrangement, including PMP22 triplication.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age of Onset
  • Charcot-Marie-Tooth Disease / genetics*
  • Charcot-Marie-Tooth Disease / pathology
  • Chromosomes, Human, Pair 17 / genetics
  • DNA Mutational Analysis
  • Family Health
  • Female
  • Gene Dosage*
  • Gene Duplication*
  • Humans
  • Male
  • Middle Aged
  • Myelin Proteins / genetics*
  • Pedigree
  • Phenotype
  • Severity of Illness Index

Substances

  • Myelin Proteins
  • PMP22 protein, human